|
Sign In to gain access to subscriptions and/or personal tools.
|
Vitamin D and Placental-Decidual Function
Katie N. Evans, BMedSc
Judith N. Bulmer, PhD
Mark D. Kilby, MD
Division of Medical Sciences, Institute of Biomedical Research, The University of Birmingham, Queen Elizabeth Hospital, Birmingham; Department of Pathology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle-upon-Tyne; Department of Fetal Medicine, Birmingham Women's Hospital, Birmingham, United Kingdom
Martin Hewison, PhD
Division of Medical Sciences, Institute of Biomedical Research, The University of Birmingham, Queen Elizabeth Hospital, Birmingham; Department of Pathology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle-upon-Tyne; Department of Fetal Medicine, Birmingham Women's Hospital, Birmingham, United Kingdom; M.Hewison{at}bham.ac.uk
The active form of vitamin D (1,25-dihydroxyvitamin D3, 1,25[OH]2D3) has well-established effects on bone metabolism and mineral homeostasis. However, recently it has become clear that 1,25(OH)2D3 has potent antiproliferative and immunomodulatory actions that are not immediately linked to its role as a skeletal regulator. Both the nuclear receptor for 1,25(OH)2D3 (vitamin D receptor, VDR) and the vitamin D-activating enzyme 1 -hydroxylase are expressed in a wide variety of nonclassic tissues, highlighting the potential for local autocrine-paracrine responses rather than traditional endocrine effects. Prominent among the tissues that express 1 -hydroxylase is the placenta-decidua, and this has raised important questions concerning the potential role of locally generated 1,25(OH)2D3 as a modulator of fetal-placental development and function. When bound to the VDR, 1,25(OH)2D3 regulates key target genes associated with implantation, such as HOXA10, whereas the potent immunosuppressive effects of 1,25(OH)2D3 suggest a role in implantation tolerance. These observations are further supported by data from our group showing increased expression of 1 hydroxylase and VDR in first-trimester trophoblast and decidua from human pregnancies. Studies by other groups have reported abnormal expression of 1 -hydroxylase in preeclamptic pregnancies, revealing a poential role for 1,25(OH)2D3 as a regulator of placentation. The effect of vitamin D on reproduction has been further endorsed by murine gene knockout models for 1 -hydroxylase and VDR, both of which are infertile. These observations and other are discussed in this article in which we postulate an active role for 1,25(OH)2D3 in placenta-decidua. In particular, we describe how induction of the vitamin Dactivating enzyme 1 -hydroxylase in early gestation might provide a mechanism by which environmental or dietary vitamin D can influence fetal-placental development.
Key Words: Vitamin D 1 -hydroxylase placenta decidua implantation
Journal of the Society for Gynecologic Investigation, Vol. 11, No. 5,
263-271 (2004)
DOI: 10.1016/j.jsgi.2004.02.002

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. M. Bodnar, H. N. Simhan, R. W. Powers, M. P. Frank, E. Cooperstein, and J. M. Roberts
High Prevalence of Vitamin D Insufficiency in Black and White Pregnant Women Residing in the Northern United States and Their Neonates
J. Nutr.,
February 1, 2007;
137(2):
447 - 452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Evans, L. Nguyen, J. Chan, B. A. Innes, J. N. Bulmer, M. D. Kilby, and M. Hewison
Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on Cytokine Production by Human Decidual Cells
Biol Reprod,
December 1, 2006;
75(6):
816 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Du, G. S. Daftary, S. I. Lalwani, and H. S. Taylor
Direct Regulation of HOXA10 by 1,25-(OH)2D3 in Human Myelomonocytic Cells and Human Endometrial Stromal Cells
Mol. Endocrinol.,
September 1, 2005;
19(9):
2222 - 2233.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|